This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) inched 0.28% higher to $161.63 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.09% to 4,076.57 and Dow Jones Industrial Average falling 0.56% to 34,395.01. This was the stock's second consecutive day of gains. AbbVie Inc. closed $14.28 short of its 52-week high ($175.91), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.42% to $178.74 and Pfizer Inc. (PFE) rose 1.90% to $51.08. Trading volume (5.8 M) eclipsed its 50-day average volume of 5.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2022.
(END) Dow Jones Newswires
December 01, 2022 16:33 ET (21:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.